News
BP Faces Declines in EPS, Revenue
BP (NYSE:BP), a global oil and gas company, released its fourth-quarter earnings on Feb. 11, 2025, showing results below expectations. The company reported an EPS of $0.44, which fell short of the
Is Summit Therapeutics a Millionaire Maker?
Few companies in the biotech industry have performed better in the past two years than Summit Therapeutics (NASDAQ: SMMT). The drugmaker's shares are up by nearly 540%, thanks to excellent clinical
Prediction: Sea Limited Stock Will Soar Over the Next 5 Years. Here Are 3 Reasons Why
In the universe of e-commerce conglomerates, Sea Limited (NYSE: SE) is easy to bypass.
It's based in Singapore, and its e-commerce and fintech businesses operate primarily in Southeast Asia. While
Is It Time to Buy AT&T Ahead of a Big Buyback?
While much of the investing world has been focused on artificial intelligence, one under-the-radar stock winner over the past year has been AT&T (NYSE: T). Shares of the telecom giant are up by more
Prudential Financial (PRU) Q4 2024 Earnings Call Transcript
Image source: The Motley Fool.
Prudential Financial (NYSE: PRU)Q4 2024 Earnings CallFeb 05, 2025, 11:00 a.m. ET
Operator
Source Fool.com
Better Dividend Stock: Realty Income vs. AT&T
Realty Income (NYSE: O) and AT&T (NYSE: T) are both popular stocks for income-oriented dividend investors. Realty is one of the world's largest real estate investment trusts (REITs), and AT&T is one
Is It Too Late to Buy AT&T Stock for the High-Yield Dividend?
From the end of 2023 through Jan. 28, shares of AT&T (NYSE: T) rose 48%. Although it had been offering an ultra-high dividend yield, the company hasn't altered its payout since reducing it in 2022.
Is AT&T an Undervalued Dividend Stock?
AT&T (NYSE: T) reported excellent quarterly results that increased the stock price.
*Stock prices used were the afternoon prices of Jan. 28, 2025. The video was published on Jan. 30, 2025.
Up More Than 500% in 12 Months, Is It Too Late to Buy Summit Therapeutics Stock?
It can be exciting to buy a stock that has been red hot and to jump on the bandwagon -- but doing so can come with significant risks. At some point, there's a danger that the stock's rally could
Buy This Dividend Stock While It's Still a Bargain
Shares of telecom giant AT&T (NYSE: T) were surging on Monday for good reason. The company reported estimate-busting results, reiterated its 2025 outlook, and updated investors on its debt reduction
The Secret to AT&T's Monster Quarter
Telecom giant AT&T (NYSE: T) beat expectations on all fronts when it reported its fourth-quarter results on Monday. There was a lot for investors to like. The company hit or exceeded all its
AT&T's 4.7%-Yielding Dividend Is Growing Increasingly Safe and Secure
Dividend sustainability concerns have weighed on AT&T (NYSE: T) in recent years. The telecom giant had previously cut its payout by nearly 50% in 2022 to retain additional cash to invest in its
Why AT&T Stock Is Soaring Today
AT&T (NYSE: T) stock is seeing big gains in Monday's trading despite a bearish backdrop for the broader market. The company's share price was up 7% as of 3:15 p.m. ET. Meanwhile, the S&P 500
AT&T; (T) Q4 2024 Earnings Call Transcript
Image source: The Motley Fool.
AT&T (NYSE: T)Q4 2024 Earnings CallJan 27, 2025, 8:30 a.m. ET
Operator
Source Fool.com
AT&T Surpasses Q4 Earnings Expectations
Telecommunications giant AT&T (NYSE:T) reported fourth-quarter and full-year 2024 earnings on Monday, Jan. 27, that topped analyst consensus estimates. Adjusted earnings per share (EPS) of $0.54
The Smartest Cheap Stocks to Buy With $1,000 Right Now
Finding genuinely cheap stocks in a pricey stock market can be tough. Some stocks may look cheap based on standard valuation metrics, but they're anything but once you factor in their growth
Should You Buy AT&T Stock Before Jan. 27?
AT&T (NYSE: T) is a leading telecom provider in the U.S. While investors often load up on the stock for its dividend, it has also generated some decent returns over the past year. During that
Why Summit Therapeutics Stock Is Jumping Today
Shares of Summit Therapeutics (NASDAQ: SMMT) had jumped 14.3% at 11:31 a.m. ET on Tuesday. The nice gain came after reports that H.C. Wainwright analyst Mitchell Kapoor maintained a "buy" rating for
AT&T's Brilliant Move Could Boost Growth in 2025
Telecom giant AT&T (NYSE: T) has been steadily gaining wireless and fiber internet subscribers over the past few years. Over the two-year period that ended on Sept. 30, AT&T grew its total wireless
Why Summit Therapeutics Rocketed 584% in 2024
Shares of biotech Summit Therapeutics (NASDAQ: SMMT) skyrocketed 583.7% in 2024, according to data from S&P Global Market Intelligence.
Summit was an early-stage biotechnology stock heading into the
HSBC appoints Lisa McGeough as President and CEO for the United States
HSBC announced that Lisa McGeough has officially been appointed President and Chief Executive Officer for the United States, effective January 1, 2025. In this role, Lisa will lead the next phase
The Best Dividend Stocks to Buy in 2025
The best dividend stocks can provide you with bountiful streams of passive income. With their lower risk and volatility profiles, these stalwart stocks should also help you protect your wealth while
Where Is SoFi Heading in 2025? 3 Bold Predictions for Investors
SoFi (NASDAQ: SOFI) is one of my highest-conviction stock ideas as we head into 2025. Not only has the fintech company maintained fantastic growth momentum for several years, including during 2022's
How Likely Is the Strategic Bitcoin Reserve and How Will It Impact Bitcoin's Price?
Thanks to this year's rally in Bitcoin (CRYPTO: BTC), which recently broke through the $100,000 price level, the concept of a strategic Bitcoin reserve has rapidly transformed from an arcane
Where Will Summit Therapeutics Be in 5 Years?
Summit Therapeutics (NASDAQ: SMMT) has risen in prominence in the past two years thanks to a promising pipeline candidate, ivonescimab, a potential cancer treatment. The company's shares are up by



